Search

Displaying 1 - 10 of 374
Orlando, FL—April 17, 2017—Merck been selected to receive the 2017 Corporate Innovator Award from the National Kidney Foundation (NKF) at its 26th annual Spring Clinical Meetings held in Orlando, Florida. Merck’s innovative new treatment for hepatitis C, ZEPATIER, is the only direct anti-viral agent specifically tested and approved for use in patients with chronic kidney disease stages 4 and 5.        “Hepatitis C...
  Keryx Biopharmaceuticals recognized for iron deficiency anemia treatment approved for early-stage chronic kidney disease patients   New York, NY—April 3, 2018—Keryx Biopharmaceuticals has been selected to receive the 2018 Corporate Innovator Award from the National Kidney Foundation (NKF) at its 27th annual Spring Clinical Meetings in Austin, Texas. In November 2017, Keryx Biopharmaceutical’s received expanded FDA approval of...
  Company recognized for treatment recently approved in the U.S. for adults at risk of rapidly progressing Autosomal Dominant Polycystic Kidney Disease   New York, NY — May 2, 2019 – Otsuka Pharmaceutical Company, Ltd. has been selected to receive the 2019 Corporate Innovator Award from the National Kidney Foundation (NKF) at the 2019 Spring Clinical Meetings in Boston.   In April 2018, Otsuka’s JYNARQUETM (...

New York, NY — The National Kidney Foundation (NKF) is honoring Relypsa, Inc. with its first-ever Corporate Innovator Award in recognition of the biopharmaceutical company’s breakthrough development of Veltassa, the first new hyperkalemia (high-potassium) treatment medicine approved by the FDA in over 50 years. This new drug will offer an additional treatment option for patients with kidney failure who have high potassium levels.

...

Company recognized for developing the first new treatment for diabetic kidney disease (DKD) to be approved by the FDA in nearly two decades.   March 20, 2020, New York, NY —Janssen Pharmaceuticals Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson has been selected to receive the 2020 Corporate Innovator Award from the National Kidney Foundation (NKF) as part of the annual ...

New York, NY – The National Kidney Foundation (NKF) has expanded its robust offerings to provide new membership opportunities for corporations.

NKF’s Corporate Membership Program is designed to give members timely industry updates, exclusive invitations to roundtable meetings, recognition, and access to key opinion leaders. Charter members of the new program represent a wide array of healthcare industry leaders....

Learn more about our Corporate Membership Program and national partners that play an important role in supporting our mission while furthering their business objectives. Corporate Membership Program National Partners Ways to Get Involved We invite corporate America to join our efforts in developing and implementing world class educational initiatives...

The National Kidney Foundation thanks those corporate supporters who have helped us further our mission of awareness, prevention and treatment of kidney disease in 2014.

AbbVie Alexion AMAG Pharmaceuticals Amgen Astellas Pharma U.S., Inc....

It's Walk Talk Wednesday and today we would like to recognize our Top Corporate Teams from across the country for the Spring 2012 Kidney Walk season.  A special congratulations to our Top Corporate Team Z-Team who participated in the Northern New Jersey Kidney Walk.  Z-Team raised $35,335 to support the 2012 Kidney Walk!!! Thank You Z-Team! Below is a full list of our Top 25 Corporate Teams for the 2012 Spring Kidney Walks.  Check back next...
Blog: Kidney Walk Talk